Frovatriptan as preemptive treatment for fasting-induced migraine

Headache

Volumn 51, Issue 3, 2011, Pages 369-374

  Latsko, Meryl ^a   Silberstein, Stephen ^a   Rosen, Noah ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Albert Einstein University   (United States)

Author keywords

Hunger induced migraine; Migraine prevention; Migraine trigger; Triptan

Indexed keywords

FROVATRIPTAN; PLACEBO;

ARTICLE; CHEST TIGHTNESS; COLD HAND; DEMOGRAPHY; DIET RESTRICTION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; HAND DISEASE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CARBAZOLES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FASTING; FEMALE; HALF-LIFE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PILOT PROJECTS; SEROTONIN RECEPTOR AGONISTS; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 79952279949     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01827.x     Document Type: Article

References (16)

1. Silberstein SD, Elkind AH, Schreiber C, Keywood C. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology. 2004;63:261-269. (Pubitemid 38971124)
2. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(Suppl. 1):9-160.
3. Peroutka SJ. Serum glucose regulation and headache. Headache. 2002;42:303-308. (Pubitemid 34568906)
4. Karli N, Zarifoglu M, Calisir N, Akgoz S. Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: Do they share similar clinical pathophysiology? Cephalalgia. 2005;25:444-451. (Pubitemid 40769864)
5. Bank J, Marton S. Hungarian migraine epidemiology. Headache. 2000;40:164-169. (Pubitemid 30132058)
6. Chabriat H, Danchot J, Michel P, Joire JE, Henry P. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache. 1999; 39:335-338. (Pubitemid 29269390)
7. Fukui PT, Goncalves TR, Strabelli CG, et al. Trigger factors in migraine patients. Arq Neuropsiquiatr. 2008;66:494-499.
8. Mosek A,Korczyn AD. Yom Kippur headache. Neurology. 1995;45:1953-1955.
9. Drescher MJ, Elstein Y. Prophylactic COX 2 inhibitor: An end to the Yom Kippur headache. Headache. 2006;46:1487-1491. (Pubitemid 44722186)
10. Drescher MJ, Alpert EA, Zalut T, Torgovicky R, Wimpfheimer Z. Prophylactic etoricoxib is effective in preventing Yom Kippur Headache: A placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. Headache. 2009;50:1328-1334.
11. Torelli P, Evangelista A, Bini A, Castellini P, Lambru G, Manzoni GC. Fasting headache: A review of the literature and new hypotheses. Headache. 2009;49:744-752.
12. Awada A, al Jumah M. The first-of-Ramadan headache. Headache. 1999;39:490-493.
13. Gill P, Guest C, Rabey P, Buggy D. Perioperative headache and day case surgery. Eur J Anaesthesiol. 2005;20:401-403.
14. Jacome DE. Hypoglycemia rebound migraine. Headache. 2001;41:895-898. (Pubitemid 33043155)
15. Blau JN. Water deprivation:Anew migraine precipitant. Headache. 2005;45:757-759.
16. Ahn AH, Basbaum AI. Tissue injury regulates serotonin 1D receptor expression: Implications for the control of migraine and inflammatory pain. J Neurosci. 2006;26:8332-8338. (Pubitemid 44309847)